Your browser doesn't support javascript.
loading
A Response to: Letter to the Editor Regarding "Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants".
Perdrizet, Johnna; Horn, Emily K; Nua, Winniefer; Perez-Peralta, Judith; Nailes, Jennifer; Santos, Jaime; Ong-Lim, Anna.
Affiliation
  • Perdrizet J; Global Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA. johnna.perdrizet@pfizer.com.
  • Horn EK; Global Health Economics and Outcomes Research, Pfizer Inc., 235 42nd Street, New York, NY, 10017, USA.
  • Nua W; Pfizer Inc., Makati City, Philippines.
  • Perez-Peralta J; Pfizer Inc., Makati City, Philippines.
  • Nailes J; Research Institute for the Health Sciences, University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines.
  • Santos J; Infectious Diseases Section, Philippine Children's Medical Center, Quezon City, Philippines.
  • Ong-Lim A; Infectious and Tropical Disease, Department of Pediatrics, College of Medicine-Philippine General Hospital, University of the Philippines, Manila, Philippines.
Infect Dis Ther ; 11(3): 1301-1303, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35474191
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Infect Dis Ther Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Infect Dis Ther Year: 2022 Document type: Article